Shell Eggs

Shell Eggs Antitrust Litigation alleges that major shell egg producers and processors coordinated on supply and pricing decisions, inflating prices paid by direct and indirect purchasers of shell eggs. Centralized in the Western District of Wisconsin in February 2026, the docket carries 21 pending actions just months after centralization — a claim population that reached a meaningful size quickly, consistent with a broad, readily identifiable purchaser base across food retail, foodservice, and manufacturing.

For a funder, this is a very early-stage matter: the speed with which the docket accumulated 21 actions is informative about the breadth of the affected purchaser class, but it says little about how quickly class certification, a damages methodology, or a settlement framework will develop. Claim files at this stage are likely to be thinner than in a docket with years of discovery behind it, and funding terms should reflect that reality rather than the eventual scale the docket may reach.

Grocery retailers, foodservice distributors, and food manufacturers with documented shell-egg purchase volumes during the relevant period are the relevant claimant pool for commercial claim funding — not a medical-lien matter. A firm building a book of purchaser clients here is a plausible early portfolio finance candidate under Criterica Capital's commercial litigation finance line, though pricing should account for the docket's still-undeveloped procedural posture at this early stage. A structure and litigation brief tracking this docket's development is also available.

Pre-settlement funding is a non-recourse purchase of a portion of the proceeds of a pending legal claim — not a loan. If the case does not result in a recovery, nothing is owed. Rates, fees, and repayment terms are disclosed in full in the funding agreement, which the applicant’s attorney reviews before signing. Availability and terms vary by state.